Skip to main content
. Author manuscript; available in PMC: 2024 May 23.
Published in final edited form as: Ann Surg Oncol. 2023 Jun 19;30(9):5667–5680. doi: 10.1245/s10434-023-13630-0

Table 4.

Subgroup comparison of postoperative complications in staged versus coordinated procedures stratified by mastectomy vs. lumpectomy

Postoperative
complication
Lumpectomy/Post-lumpectomy Reconstruction and
BSO
Mastectomy/Post-mastectomy Reconstruction
and BSO
Coordinated
(N=85)
n (%)
Staged
(N=1328)
n (%)
P-value Coordinated
(N=327)
n (%)
Staged
(N=2487)
n (%)
P-value
Surgical Site Infection 3 (3.5%) 51 (3.8%) 1.0 42 (12.8%) 198 (8.0%) <0.01
Seroma 6 (7.1%) 61 (4.6%) 0.29 27 (8.3%) 150 (6.0%) 0.14
Implant Removal *** *** *** 12 (3.7%) 60 (2.4%) 0.19
Hematoma 1 (1.2%) 17 (1.2%) 1.0 15 (4.6%) 74 (3.0%) 0.13
Blood transfusion 0 (0%) 0 (0%) 1.0 0 (0%) 1 (<0.1%) 1.0
Wound dehiscence 2 (2.4%) 30 (2.3%) 1.0 18 (5.5%) 196 (7.9%) 0.15
Ileus 2 (2.4%) 16 (1.2%) 0.30 3 (0.9%) 20 (0.8%) 0.74
Cardiac 0 (0%) 1 (0.1%) 1.0 1 (0.3%) 5 (0.2%) 0.52
Respiratory 0 (0%) 0 (0%) 1.0 1 (0.3%) 4 (0.2%) 0.46
DVT/PE 0 (0%) 10 (0.8%) 1.0 10 (3.1%) 29 (1.2%) 0.01
Any complication 11 (12.9%) 155 (11.7%) 0.73 88 (26.9%) 519 (20.9%) 0.01